New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials

BACKGROUND: New direct-acting antiviral agents (DAAs) approved for the treatment of patients infected by Hepatitis C virus (HCV) are well tolerated and increase sustained virological response (SVR) rate. We summarize current evidence on the efficacy and safety from comparative randomized controlled...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Exp Hepatol
Main Authors: Pecoraro, Valentina, Banzi, Rita, Cariani, Elisabetta, Chester, Johanna, Villa, Erica, D'Amico, Roberto, Bertele', Vittorio, Trenti, Tommaso
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6728536/
https://ncbi.nlm.nih.gov/pubmed/31516269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.07.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados